Sanders Robinson v. HHS - Tdap, Guillain-Barré Syndrome (2022)

Sanders Robinson filed a petition for compensation under the National Vaccine Injury Compensation Program on May 16, 2019, alleging he developed Guillain-Barré Syndrome (GBS) after receiving a tetanus-diptheria-acellular pertussis (Tdap) vaccine on November 28, 2016. The respondent denied that the Tdap vaccine caused Mr.

Robinson's GBS or any other injury. Despite the respondent's denial, the parties reached a settlement.

The Special Master adopted their joint stipulation, awarding Mr. Robinson compensation.

The award includes a lump sum of $147,512.94, representing $46,821.49 for first-year life care expenses, $100,000.00 for pain and suffering, and $691.45 for past unreimbursable expenses, payable to the petitioner. Additionally, an amount sufficient to purchase an annuity contract was awarded, paid to the life insurance company from which the annuity will be purchased.

These amounts represent compensation for all damages available under the program. The decision was issued by Special Master Mindy Michaels Roth on June 21, 2022.

The public decision does not describe the onset of symptoms, specific medical tests, treatments, or expert witnesses. Diana L.

Stadelnikas, Esq., represented the petitioner, and Mark K. Hellie, Esq., represented the respondent.